Summary of opinion: Simparica Trio, 12/02/2025 Positive

Conversations on cancer - cervical cancer treatment innovation: a collaborative discussion , European Medicines Agency, Amsterdam, the Netherlands, from 14 January 2025, 16:00 (CET) to 14 January 2025, 17:00 (CET)

Records of data processing activity regarding the processing of personal data in the Clinical Trials Information System (CTIS)

Product Management Service (PMS) – Frequently Asked Questions (FAQs)

Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

Article 57 product data

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2025

Guideline on assessment and reporting of mechanistic models used in the context of model informed drug development

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2025 to 16 May 2025